Informazioni sul sito:

Nome del dominio - humanize.it

Titolo del sito - humanize.it

Vai al sito web - humanize.it

Posizione GEO del sito

Posizione Paese - United States

Paese di registrazione - Australia

Città/Paese - San Diego

Fornitore - Trellian Pty. Limited

Site Logo

indirizzo IP:

103.224.182.246

Server dei nomi di dominio:

ns18.abovedomains.com ns17.abovedomains.com

Tutti i record:

☆ humanize.it. 21600 IN NS ns1.abovedomains.com.
☆ humanize.it. 57 IN SOA ns1.abovedomains.com. hostmaster.trellian.com. 2024060301 10800 3600 604800 3600
☆ humanize.it. 3597 IN MX 10 park-mx.above.com.
☆ humanize.it. 3597 IN TXT "v=spf1 ip6:fdcf:abda:4154::/48 -all"
☆ humanize.it. 21600 IN NS ns2.abovedomains.com.
☆ humanize.it. 3597 IN TXT "0ad094978b47130a6a809a0396525cae21191ed6"
☆ humanize.it. 3597 IN A 103.224.182.246

Brief facts about humanize:

Humanized antibodies are antibodies from non-human species whose protein sequences have been modified to increase their similarity to antibody variants produced naturally in humans. The process of "humanization" is usually applied to monoclonal antibodies developed for administration to humans. Humanization can be necessary when the process of developing a specific antibody involves generation in a non-human immune system. The protein sequences of antibodies produced in this way are partially distinct from homologous antibodies occurring naturally in humans, and are therefore potentially immunogenic when administered to human patients. The International Nonproprietary Names of humanized antibodies end in -zumab, as in omalizumab. Humanized antibodies are distinct from chimeric antibodies. The latter also have their protein sequences made more similar to human antibodies, but carry a larger stretch of non-human protein. There are other ways to develop monoclonal antibodies.

Monoclonal antibodies